E. Lund

发表

Near-patient test for C-reactive protein in general practice: assessment of clinical, organizational, and economic outcomes.

T Lauritzen, E D Lund, I. Brandslund, 1999, Clinical chemistry.

Evaluation of a near-patient test for C-reactive protein used in daily routine in primary healthcare by use of difference plots.

P H Petersen, T Lauritzen, E D Lund, 1997, Clinical chemistry.

Glycemic control in diabetes in three Danish counties

P. H. Petersen, I. Brandslund, H. Møller, 2005, Clinical chemistry and laboratory medicine.

S and Z a1-antitrypsin alleles are risk factors for bronchial hyperresponsiveness in young farmers: an example of gene/ environment interaction

I. Brandslund, M. Miller, O. Pedersen, 2022 .

Low normal alpha-1-antitrypsin serum concentrations and MZ-phenotype are associated with byssinosis and familial allergy in cotton mill workers.

I. Brandslund, E. Lund, T. Sigsgaard, 1994, Pharmacogenetics.

Is a low serum concentration of alpha 1-antitrypsin associated with an increased susceptibility for byssinosis in cotton mill workers? Considerations regarding analytical quality requirements and economical consequences.

I. Brandslund, E. Lund, T. Sigsgaard, 1993, Upsala journal of medical sciences.

Platelets and Anticoagulant Capacity in Patients with Inflammatory Bowel Disease

I. Brandslund, P. Munkholm, E. Lund, 2002, Pathophysiology of Haemostasis and Thrombosis.

Patient pools and the use of “patient means” are valuable tools in quality control illustrated by a bone-specific alkaline phosphatase assay

I. Brandslund, T. Plesner, E. Lund, 2016, Clinical chemistry and laboratory medicine.

Predicting brain metastases of breast cancer based on serum S100B and serum HER2

I. Brandslund, K. Steffensen, E. Lund, 2013, Oncology letters.

[Resistance to activated protein C. The most common cause of familial thrombophilia].

I. Brandslund, J. Lassen, E. Lund, 1996, Ugeskrift for laeger.

Reasons for a laboratory's inability to report results for requested analytical tests.

M Stahl, E D Lund, I Brandslund, 1998, Clinical chemistry.

Specificities of monoclonal antibodies against the complement C3d split product.

I. Brandslund, E. Lund, L. S. Sørensen, 1990, Complement and inflammation.

C-reactive protein in general practice--how commonly is it used and why?

I. Brandslund, T. Lauritzen, B. Dahler-Eriksen, 1997, Scandinavian journal of primary health care.

Diabetes mortality differs between registers due to various disease definitions.

I. Brandslund, A. Green, C. Christensen, 2014, Danish medical journal.